Epidemiology (Cambridge, Mass.)
Comparing area-level patient density and physician prescribing preference instruments for the effect of antidiabetics on adverse cardiovascular events among Medicare beneficiaries.
Jack Cordes, Robert J Glynn, Alexander M Walker, Sebastian S Schneeweiss
Published: 202510.1097/EDE.0000000000001938
Abstract
BACKGROUND: Randomized trials (RCT) of major adverse cardiovascular events found no effect of dipeptidyl-peptidase-4 inhibitors (DPP-4i) medications compared to second-generation sulfonylureas while non-randomized studies estimated a benefit of DPP-4…
Preview only. Read the full abstract at the source